These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6868525)

  • 21. Diffuse interstitial renal tuberculosis--an unusual cause of renal failure.
    Mallinson WJ; Fuller RW; Levison DA; Baker LR; Cattell WR
    Q J Med; 1981; 50(198):137-48. PubMed ID: 7302115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elimination of isoniazid in patients with impaired renal function.
    Reidenberg MM; Shear L; Cohen RV
    Am Rev Respir Dis; 1973 Dec; 108(6):1426-8. PubMed ID: 4751732
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetics of nicotine in kidney failure.
    Molander L; Hansson A; Lunell E; Alainentalo L; Hoffmann M; Larsson R
    Clin Pharmacol Ther; 2000 Sep; 68(3):250-60. PubMed ID: 11014406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased acetylation of isoniazid in chronic renal failure.
    Kim YG; Shin JG; Shin SG; Jang IJ; Kim S; Lee JS; Han JS; Cha YN
    Clin Pharmacol Ther; 1993 Dec; 54(6):612-20. PubMed ID: 8275616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [How to prescribe drugs in the presence of functional renal deficiencies. Tables of dosage adjustment].
    Fabre J
    Schweiz Med Wochenschr; 1972 Feb; 102(8):251-6. PubMed ID: 5010514
    [No Abstract]   [Full Text] [Related]  

  • 26. [Specific features of chemotherapy of tuberculosis of the urinary system in patients with chronic renal insufficiency].
    Mochalova TP; Danilova NK; Dovlatian AA
    Ter Arkh; 1977; 49(7):79-81. PubMed ID: 898083
    [No Abstract]   [Full Text] [Related]  

  • 27. Renal handling of inorganic sulfate in children with chronic kidney disorders.
    Michalk D; Manz F; Muller-Wiefel DE; Scharer K
    Miner Electrolyte Metab; 1982 Nov; 8(5):255-60. PubMed ID: 7167133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ofloxacin pharmacokinetics in renal failure.
    Couet W; Mignot A; Lefebvre M; Akbaraly J; Fourtilan J; Fillastre J; Leroy A; Humbert G
    Chemioterapia; 1987 Jun; 6(2 Suppl):313-4. PubMed ID: 3509428
    [No Abstract]   [Full Text] [Related]  

  • 29. Update on renal disease for the dental practitioner.
    Kerr AR
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jul; 92(1):9-16. PubMed ID: 11458240
    [No Abstract]   [Full Text] [Related]  

  • 30. Decreased volume of distribution of digoxin in a patient with renal failure.
    Szefler SJ; Jusko WJ
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):1095-8. PubMed ID: 4760884
    [No Abstract]   [Full Text] [Related]  

  • 31. [Dosage of antibiotics in patients with reduced renal function].
    von der Lippe E
    Tidsskr Nor Laegeforen; 2002 Oct; 122(25):2461-3. PubMed ID: 12448117
    [No Abstract]   [Full Text] [Related]  

  • 32. [Plasma level and half-life of proscillaridine in healthy and renal failure persons].
    Belz GG; Brech W; Rudofsky G; Härich B; Nissen H; Franz E; Stauch M
    Verh Dtsch Ges Inn Med; 1973; 79():1044-7. PubMed ID: 4799537
    [No Abstract]   [Full Text] [Related]  

  • 33. [Neutron activation analysis in studying chronic renal insufficiency].
    Gorovenko VI
    Urol Nefrol (Mosk); 1980; (4):49-54. PubMed ID: 7394945
    [No Abstract]   [Full Text] [Related]  

  • 34. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic renal failure and nephrolithiasis in a solitary kidney: role of intervention.
    Goel MC; Ahlawat R; Kumar M; Kapoor R
    J Urol; 1997 May; 157(5):1574-7. PubMed ID: 9112479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic clearance of recombinant human growth hormone in health and chronic renal failure.
    Haffner D; Schaefer F; Girard J; Ritz E; Mehls O
    J Clin Invest; 1994 Mar; 93(3):1163-71. PubMed ID: 8132756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.
    Arancibia A; Drouguett MT; Fuentes G; González G; González C; Thambo S; Palombo G
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):447-53. PubMed ID: 7141752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ciprofloxacin and oxociprofloxacin pharmacokinetics in patients on haemodialysis.
    Drinovec J; Mrhar A; Bren A; Primozic S; Karba R; Varl J; Kozjek F
    J Chemother; 1989 Jul; 1(4 Suppl):565-6. PubMed ID: 16312534
    [No Abstract]   [Full Text] [Related]  

  • 39. Renal function and outcomes in acute coronary syndrome: impact of clopidogrel.
    Keltai M; Tonelli M; Mann JF; Sitkei E; Lewis BS; Hawken S; Mehta SR; Yusuf S;
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):312-8. PubMed ID: 17446813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clearance concept applied to pharmacokinetics: 2. Experience with tolamolol (beta-blocking agent) in renal insufficiency (author's transl)].
    Balant L; Gorgia A; Marmy A; Tschopp JM
    Nephrologie; 1980; 1(4):177-82. PubMed ID: 6895408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.